Table 4 HCV support services and treatment provided onsite at DCRs/SIFs and availability of HCV treatment to DCR clients
Provide onsite | Plan to expand in future | |
|---|---|---|
HCV support (multiple responses possible) | n = 46 | n = 47 |
Yes, referral to other services that can provide HCV treatment | 96% | 36% |
Yes, disease self-management support (e.g. healthy diet, obesity) | 50% | 15% |
Yes, liver health/cirrhosis monitoring (e.g. fibro-scan, blood test) | 24% | 11% |
No | 15% | 49% |
HCV treatment (one response only) | n = 48 | n = 39 |
Yes, new HCV treatment forms (DAAs) | 4% | 3% |
Yes, interferon-based treatment | 0% | 3% |
Yes, both treatment options | 4% | 0% |
Other (provided details) | – | 10% |
Don’t know | 8% | – |
No | 86% | 84% |